Effects of Computerized Guideline-Oriented Clinical Decision Support System on Glycemic Control in Diabetic Patients:...

Area of Science:

• Health Informatics
• Clinical Decision Support Systems
• Diabetes Management

Background:

• Glycated hemoglobin (HbA1C) is a key marker for diabetes control.
• Clinical Decision Support Systems (CDSS) aim to improve healthcare provider decision-making.
• Previous studies show mixed results on the effectiveness of computerized CDSS in diabetes management.

Purpose of the Study:

• To evaluate the impact of computerized guideline-oriented CDSS on HbA1C levels and control in patients with diabetes.
• To assess the proportion of patients achieving target HbA1C levels (≥7.0%) with CDSS intervention compared to standard care.

Main Methods:

• Meta-analysis of 4 randomized controlled trials.
• Comparison of outcomes between patients using computerized CDSS and a control group.
• Analysis of changes in HbA1C from baseline to follow-up and the proportion of patients with HbA1C ≥ 7.0%.

Main Results:

• No significant difference in the change of HbA1C from baseline to follow-up (WMD: -0.29, 95% CI: -0.74 to 0.16, p=0.212).
• A statistically significant reduction in the proportion of patients with HbA1C ≥ 7.0% at follow-up (OR: 0.85, 95% CI: 0.74 to 0.97, p=0.014).

Conclusions:

• Computerized CDSS interventions show potential in improving glycemic control by reducing the proportion of patients with uncontrolled diabetes.
• The findings suggest that while overall HbA1C changes may not be significant, CDSS can help achieve target glycemic control in a greater proportion of patients.
• Further development of multifaceted computerized CDSS is warranted to maximize benefits in diabetes management.